Status:
RECRUITING
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Pennsylvania Department of Health
Conditions:
Cirrhosis, Liver
End Stage Liver DIsease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investiga...
Detailed Description
Liver cirrhosis is a chronic condition with a high symptom burden, morbidity, mortality and costs. Common symptoms and reasons for hospitalizations in cirrhosis are 'fluid overload' (e.g. abdominal an...
Eligibility Criteria
Inclusion
- English speaking
- Aged 18 years or older
- Home-dwelling
- Diagnosis of cirrhosis- Child Turcotte-Pugh (CTP) B or C or a complication in the past 6 months (CTP B or higher, hepatic encephalopathy, variceal bleeding, fluid overload, liver-related hospitalization, or requiring symptom management with diuretics, non-absorbable disaccharides, rifaximin, nonselective beta blockers)
- Patient and/or caregiver is able and willing to receive SMS text messages
- Willing and able to wear personal fitness trackers and engage with study staff
Exclusion
- No access to a smartphone
- Non-home dwelling
- On hospice care
- Model for end stage liver disease (MELD) score ≥30
- Advanced hepatocellular carcinoma, BCLC C or higher
- Hospitalization within the last 30 days
- Deemed not appropriate by treating physician for medical reasons
- Enrolled in other dietary or physical activity interventions
- Receiving physical therapy as standard of care
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06136221
Start Date
May 1 2024
End Date
May 31 2026
Last Update
July 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104